Immunodeficiency disorders and Rash erythematous

Summary:

Rash erythematous is found among people with Immunodeficiency disorders, especially for people who are male, 50-59 old.

The study analyzes which people have Rash erythematous with Immunodeficiency disorders. It is created by eHealthMe based on reports of 40 people who have Immunodeficiency disorders from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Immunodeficiency disorders?

Immunodeficiency disorders is found to be associated with 708 drugs and 941 conditions by eHealthMe. Check the latest studies of Immunodeficiency disorders.

What is Rash erythematous?

Rash erythematous (redness of the skin) is found to be associated with 1,810 drugs and 1,902 conditions by eHealthMe. Check the latest studies of Rash erythematous.



On Jul, 06, 2026

40 people who have Immunodeficiency Disorders and Rash Erythematous are studied.

Would you have Rash erythematous when you have Immunodeficiency disorders?

Gender of people who have Immunodeficiency Disorders and experienced Rash Erythematous *:

  • female: 36 %
  • male: 64 %

Age of people who have Immunodeficiency Disorders and experienced Rash Erythematous *:

  • 0-1: 0.0 %
  • 2-9: 8.7 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 21.74 %
  • 40-49: 26.09 %
  • 50-59: 30.43 %
  • 60+: 13.04 %

Common co-existing conditions for these people *:

  1. Pain In Extremity: 2 people, 5.00%
  2. Neuralgia (pain in one or more nerves): 2 people, 5.00%
  3. Joint Pain: 2 people, 5.00%
  4. Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli): 2 people, 5.00%
  5. Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 2 people, 5.00%
  6. Vision Blurred: 1 person, 2.50%
  7. Uveitis (inflammation of the uvea): 1 person, 2.50%
  8. Urinary Tract Infection: 1 person, 2.50%
  9. Scleritis (inflammation of sclera): 1 person, 2.50%
  10. Photophobia (extreme sensitivity to light): 1 person, 2.50%

Common drugs taken by these people *:

  1. Advair Hfa: 12 people, 30.00%
  2. Cellcept: 5 people, 12.50%
  3. Prednisone: 4 people, 10.00%
  4. Prograf: 4 people, 10.00%
  5. Tacrolimus: 4 people, 10.00%
  6. Depo-Provera: 2 people, 5.00%
  7. Paracetamol: 2 people, 5.00%
  8. Ciclosporin: 2 people, 5.00%
  9. Cymbalta: 2 people, 5.00%
  10. Acetaminophen: 2 people, 5.00%

Common symptoms for these people *:

  1. Weakness: 17 people, 42.50%
  2. Rash Pruritic (redness with itching): 13 people, 32.50%
  3. Graft Versus Host Disease In Lung (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the lung): 13 people, 32.50%
  4. Cytomegalovirus Infection: 13 people, 32.50%
  5. Pressure Ulcer: 12 people, 30.00%
  6. Eczema Nummular (circular or oval patches of eczema with well-defined edges): 12 people, 30.00%
  7. Myopathy (a muscular disease in which the muscle fibres do not function): 12 people, 30.00%
  8. Rashes (redness): 9 people, 22.50%
  9. Fever: 8 people, 20.00%
  10. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 7 people, 17.50%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Rash erythematous?

- Check whether Rash erythematous is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Rash erythematous:

All the conditions that are associated with Rash erythematous:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Rash erythematous and Immunodeficiency disorders, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: